CompletedNot Applicable

Multiple Myeloma Prognostic Indices

Egypt48 participantsStarted 2023-04-01

Plain-language summary

The aim of this study was to evaluate the impact of albumin / fibrinogen ratio, blood viscosity and RDW on the prognosis of a newly diagnosed MM patients

Who can participate

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients newly diagnosed with MM according to International Myeloma Working Group criteria 2016. Exclusion Criteria: * Patient previously diagnosed MM and started treatment or in post treatment follow up

What they're measuring

Determine the prognosis of newly diagnosed multiple myeloma patients in survival for one year.

Timeframe: One year

Determine the prognosis of newly diagnosed multiple myeloma patients in survival for one year.

Timeframe: One year

Determine the prognosis of newly diagnosed multiple myeloma patients in survival for one year.

Timeframe: One year

Trial details

NCT IDNCT06095752

SponsorAssiut University

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2025-04-30

View on ClinicalTrials.gov More Multiple Myeloma trials